← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2009Last known activity
Oct 7, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 4 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT05040126CollaboratorPhase 3Oct 7, 2021
- NCT02958709CollaboratorPhase 1/Phase 2Feb 22, 2017
- NCT00902967Lead sponsorPhase 3Jul 1, 2009
- NCT01095640Overall official - principal investigatorN/AMar 1, 2009
Details
- Last known activity
- Oct 7, 2021